Cargando…
The role of extracellular vesicles in acquisition of resistance to therapy in glioblastomas
Glioblastoma (GBM) is the most aggressive primary brain tumor with a median survival of 15 months despite standard care therapy consisting of maximal surgical debulking, followed by radiation therapy with concurrent and adjuvant temozolomide treatment. The natural history of GBM is characterized by...
Autores principales: | Yekula, Anudeep, Taylor, Abigail, Beecroft, Alexandra, Kang, Keiko M., Small, Julia L., Muralidharan, Koushik, Rosh, Zachary, Carter, Bob S., Balaj, Leonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019190/ https://www.ncbi.nlm.nih.gov/pubmed/35582008 http://dx.doi.org/10.20517/cdr.2020.61 |
Ejemplares similares
-
Extracellular Vesicles in Glioblastoma Tumor Microenvironment
por: Yekula, Anuroop, et al.
Publicado: (2020) -
Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma
por: Wang, Lan, et al.
Publicado: (2020) -
Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis
por: Kang, Keiko M., et al.
Publicado: (2021) -
Glioblastoma‐derived extracellular vesicle subpopulations following 5‐aminolevulinic acid treatment bear diagnostic implications
por: Hsia, Tiffaney, et al.
Publicado: (2022) -
Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity
por: Roy, Sabrina, et al.
Publicado: (2019)